NCT00290927View on ClinicalTrials.gov

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

December 31, 2003

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glulisine

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY